Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

Iuliana Vaxman^{1

2

3}, Morie Gertz¹

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Davidoff Cancer Center, Rabin Medical Center, Institute of Hematology, Petah-Tikvah, Israel.
³ Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Comment

Iuliana Vaxman et al. Leuk Lymphoma. 2020 Mar.

. 2020 Mar;61(3):504-506.

doi: 10.1080/10428194.2020.1716223. Epub 2020 Jan 24.

Iuliana Vaxman^{1

2

3}, Morie Gertz¹

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Davidoff Cancer Center, Rabin Medical Center, Institute of Hematology, Petah-Tikvah, Israel.
³ Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

No abstract available

Comment on

The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison.
Mateos MV, San-Miguel J, Goldschmidt H, Sonneveld P, Dimopoulos MA, Heeg B, Hashim M, Deraedt W, Hu P, Lam A, He J. Mateos MV, et al. Leuk Lymphoma. 2020 Mar;61(3):680-690. doi: 10.1080/10428194.2019.1675881. Epub 2019 Nov 5. Leuk Lymphoma. 2020. PMID: 31686561
Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis.
Ramasamy K, Dhanasiri S, Thom H, Buchanan V, Robinson S, D'Souza VK, Weisel K. Ramasamy K, et al. Leuk Lymphoma. 2020 Mar;61(3):668-679. doi: 10.1080/10428194.2019.1683736. Epub 2019 Nov 11. Leuk Lymphoma. 2020. PMID: 31709875
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma.
Sharpley FA, Djebbari F, Fourali S, Kothari J, Lynes JA, McLain-Smith S, Ramasamy K. Sharpley FA, et al. Leuk Lymphoma. 2020 Mar;61(3):732-736. doi: 10.1080/10428194.2019.1683737. Epub 2019 Nov 27. Leuk Lymphoma. 2020. PMID: 31771382 No abstract available.